Sovereign Metals Ltd
ASX:SVM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sovereign Metals Ltd
ASX:SVM
|
AU |
|
Pangaea Oncology SA
MAD:PANG
|
ES |
|
B
|
Brand 24 SA
WSE:B24
|
PL |
|
C
|
Cedergrenska AB
STO:CEDER
|
SE |
|
W
|
Wartsila Oyj Abp
OMXH:WRT1V
|
FI |
|
HCA Healthcare Inc
NYSE:HCA
|
US |
|
Europris ASA
LSE:0RAI
|
NO |
|
MGI Media & Games Invest SE
OTC:MGIMF
|
SE |
|
S
|
Sano Brunos Enterprises Ltd
TASE:SANO1
|
IL |
|
Beacon Lighting Group Ltd
ASX:BLX
|
AU |
|
L
|
L&C Bio Co Ltd
KOSDAQ:290650
|
KR |
|
Stylam Industries Ltd
NSE:STYLAMIND
|
IN |
Income Statement
Earnings Waterfall
Sovereign Metals Ltd
Income Statement
Sovereign Metals Ltd
| Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
-33%
|
0
-79%
|
0
-20%
|
0
-25%
|
0
+100%
|
0
+83%
|
0
+18%
|
0
-23%
|
0
-10%
|
0
-22%
|
0
-57%
|
0
+67%
|
0
-22%
|
0
-49%
|
0
+17%
|
0
+72%
|
0
+48%
|
0
-9%
|
0
+48%
|
0
-6%
|
0
-17%
|
0
-3%
|
0
-52%
|
0
-39%
|
0
-1%
|
0
+4%
|
0
+82%
|
0
+387%
|
0
+67%
|
1
+297%
|
2
+70%
|
2
+5%
|
2
+7%
|
2
-6%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(5)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(4)
|
(4)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(6)
|
(3)
|
(4)
|
(6)
|
(11)
|
(14)
|
(14)
|
(16)
|
(15)
|
(21)
|
(33)
|
(42)
|
(32)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(0)
|
(0)
|
(2)
|
(4)
|
(6)
|
(3)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
2
|
|
| Research & Development |
(5)
|
(2)
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(5)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(4)
|
(7)
|
(8)
|
(12)
|
(11)
|
(10)
|
(15)
|
(26)
|
(34)
|
(34)
|
|
| Operating Income |
(4)
N/A
|
(2)
+54%
|
(1)
+58%
|
(1)
+10%
|
(1)
+23%
|
(1)
+3%
|
(1)
-32%
|
(1)
-3%
|
(2)
-127%
|
(3)
-85%
|
(3)
+11%
|
(2)
+22%
|
(4)
-88%
|
(4)
+4%
|
(2)
+41%
|
(2)
+11%
|
(3)
-29%
|
(4)
-31%
|
(4)
-12%
|
(5)
-31%
|
(6)
-10%
|
(7)
-16%
|
(6)
+19%
|
(3)
+44%
|
(4)
-14%
|
(6)
-56%
|
(11)
-95%
|
(14)
-26%
|
(14)
-4%
|
(15)
-8%
|
(14)
+10%
|
(19)
-36%
|
(31)
-66%
|
(40)
-28%
|
(30)
+25%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
9
|
10
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(3)
+24%
|
(1)
+74%
|
(1)
+10%
|
(1)
+23%
|
(1)
+3%
|
(1)
-32%
|
(1)
-3%
|
(2)
-127%
|
(3)
-85%
|
(3)
+11%
|
(2)
+22%
|
(4)
-88%
|
(4)
+4%
|
(2)
+41%
|
(2)
+11%
|
(3)
-29%
|
(4)
-31%
|
(4)
-11%
|
(5)
-31%
|
(6)
-8%
|
(6)
-13%
|
(5)
+18%
|
(3)
+42%
|
(3)
-10%
|
(5)
-51%
|
(11)
-113%
|
(14)
-27%
|
(14)
-6%
|
(6)
+60%
|
(4)
+26%
|
(19)
-332%
|
(31)
-68%
|
(40)
-30%
|
(30)
+26%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(4)
|
(4)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(5)
|
(3)
|
(3)
|
(5)
|
(11)
|
(14)
|
(14)
|
(6)
|
(4)
|
(19)
|
(31)
|
(40)
|
(30)
|
|
| Net Income (Common) |
(4)
N/A
|
(3)
+24%
|
(1)
+74%
|
(1)
+10%
|
(1)
+23%
|
(1)
+3%
|
(1)
-32%
|
(1)
-3%
|
(2)
-127%
|
(3)
-85%
|
(3)
+11%
|
(2)
+22%
|
(4)
-88%
|
(4)
+4%
|
(2)
+41%
|
(2)
+11%
|
(3)
-29%
|
(4)
-31%
|
(4)
-11%
|
(5)
-31%
|
(6)
-8%
|
(6)
-13%
|
(5)
+18%
|
(3)
+42%
|
(3)
-10%
|
(5)
-51%
|
(11)
-113%
|
(14)
-27%
|
(14)
-6%
|
(6)
+60%
|
(4)
+26%
|
(19)
-332%
|
(31)
-68%
|
(40)
-30%
|
(30)
+26%
|
|
| EPS (Diluted) |
-0.09
N/A
|
-0.07
+22%
|
-0.02
+71%
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.02
-100%
|
-0.01
+50%
|
-0.03
-200%
|
-0.05
-67%
|
-0.03
+40%
|
-0.03
N/A
|
-0.04
-33%
|
-0.04
N/A
|
-0.02
+50%
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.03
-200%
|
-0.03
N/A
|
-0.03
N/A
|
-0.01
+67%
|
-0.01
N/A
|
-0.03
-200%
|
-0.05
-67%
|
-0.07
-40%
|
-0.05
+29%
|
|